Skip to main content

Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells.

Publication ,  Journal Article
Mo, L; Pospichalova, V; Huang, Z; Murphy, SK; Payne, S; Wang, F; Kennedy, M; Cianciolo, GJ; Bryja, V; Pizzo, SV; Bachelder, RE
Published in: PLoS One
2015

Chemotherapy resistance is the major reason for the failure of ovarian cancer treatment. One mechanism behind chemo-resistance involves the upregulation of multidrug resistance (MDR) genes (ABC transporters) that effectively transport (efflux) drugs out of the tumor cells. As a common symptom in stage III/IV ovarian cancer patients, ascites is associated with cancer progression. However, whether ascites drives multidrug resistance in ovarian cancer cells awaits elucidation. Here, we demonstrate that when cultured with ascites derived from ovarian cancer-bearing mice, a murine ovarian cancer cell line became less sensitive to paclitaxel, a first line chemotherapeutic agent for ovarian cancer patients. Moreover, incubation of murine ovarian cancer cells in vitro with ascites drives efflux function in these cells. Functional studies show ascites-driven efflux is suppressible by specific inhibitors of either of two ABC transporters [Multidrug Related Protein (MRP1); Breast Cancer Related Protein (BCRP)]. To demonstrate relevance of our findings to ovarian cancer patients, we studied relative efflux in human ovarian cancer cells obtained from either patient ascites or from primary tumor. Immortalized cell lines developed from human ascites show increased susceptibility to efflux inhibitors (MRP1, BCRP) compared to a cell line derived from a primary ovarian cancer, suggesting an association between ascites and efflux function in human ovarian cancer. Efflux in ascites-derived human ovarian cancer cells is associated with increased expression of ABC transporters compared to that in primary tumor-derived human ovarian cancer cells. Collectively, our findings identify a novel activity for ascites in promoting ovarian cancer multidrug resistance.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

PLoS One

DOI

EISSN

1932-6203

Publication Date

2015

Volume

10

Issue

7

Start / End Page

e0131579

Location

United States

Related Subject Headings

  • Paclitaxel
  • Ovarian Neoplasms
  • Neoplasm Proteins
  • Multidrug Resistance-Associated Proteins
  • Mice, Inbred C57BL
  • Mice
  • Humans
  • Genes, MDR
  • General Science & Technology
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mo, L., Pospichalova, V., Huang, Z., Murphy, S. K., Payne, S., Wang, F., … Bachelder, R. E. (2015). Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells. PLoS One, 10(7), e0131579. https://doi.org/10.1371/journal.pone.0131579
Mo, Lihong, Vendula Pospichalova, Zhiqing Huang, Susan K. Murphy, Sturgis Payne, Fang Wang, Margaret Kennedy, et al. “Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells.PLoS One 10, no. 7 (2015): e0131579. https://doi.org/10.1371/journal.pone.0131579.
Mo L, Pospichalova V, Huang Z, Murphy SK, Payne S, Wang F, et al. Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells. PLoS One. 2015;10(7):e0131579.
Mo, Lihong, et al. “Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells.PLoS One, vol. 10, no. 7, 2015, p. e0131579. Pubmed, doi:10.1371/journal.pone.0131579.
Mo L, Pospichalova V, Huang Z, Murphy SK, Payne S, Wang F, Kennedy M, Cianciolo GJ, Bryja V, Pizzo SV, Bachelder RE. Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells. PLoS One. 2015;10(7):e0131579.

Published In

PLoS One

DOI

EISSN

1932-6203

Publication Date

2015

Volume

10

Issue

7

Start / End Page

e0131579

Location

United States

Related Subject Headings

  • Paclitaxel
  • Ovarian Neoplasms
  • Neoplasm Proteins
  • Multidrug Resistance-Associated Proteins
  • Mice, Inbred C57BL
  • Mice
  • Humans
  • Genes, MDR
  • General Science & Technology
  • Female